EDTA

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: detox heart longevity

Research Overview

Across the studies reviewed here, EDTA research clusters into three heavily studied areas: (1) antimicrobial adjuvant use against multidrug-resistant Gram-negative bacteria (notably as a colistin potentiator), (2) plant/soil systems where EDTA is used to chelate metals and alter uptake/toxicity (e.g., Cd, Cu, As) for phytoremediation or mechanistic plant-stress studies, and (3) dental/endodontic applications where EDTA functions as a chelating irrigant/decalcifying agent that modifies dentin mineral/organic components and can facilitate release of matrix-associated proteins. A smaller but clinically important area represented here is cardiovascular chelation therapy, specifically an EDTA-based infusion regimen evaluated in a randomized trial context (TACT) with subgroup analyses in patients with diabetes.

The strongest evidence in this set supports EDTA’s role as a chelator that measurably changes metal ion availability and mineralized tissue chemistry, with consistent downstream biological effects. In dentistry, multiple chelators including EDTA reproducibly reduce inorganic (phosphate/carbonate) signals in dentin and can solubilize dentin-associated proteins, supporting its mechanistic utility in smear-layer removal/decalcification and as a conditioning agent in regenerative endodontics. In plant systems, EDTA reliably increases the bioavailable fraction of certain metals and can increase plant tissue accumulation (e.g., Cd in spider plants; Cu uptake in sunflower, especially when combined with IAA), though with trade-offs such as reduced biomass at higher EDTA doses—highlighting a consistent efficacy–toxicity/fitness balance. In antimicrobial research, in vitro and animal-model findings indicate EDTA can enhance colistin activity against colistin-resistant pathogens, particularly in combination regimens (e.g., with baicalin or berberine), with proposed multi-pathway mechanisms including interference with resistance determinants (e.g., effects on MCR-1-related processes) and broader impacts on bacterial physiology; however, these findings are largely preclinical in the studies reviewed here. The cardiovascular evidence is comparatively higher on the clinical-evidence hierarchy (randomized trial), with a reported reduction in composite cardiovascular outcomes in the diabetes subgroup, but interpretation remains constrained by subgroup/multiplicity considerations and the need for replication and mechanistic clarification.

Key gaps include translation and generalizability. For antimicrobial adjuvant use, more research is needed to establish clinically relevant dosing, safety (including systemic chelation effects), pharmacokinetics/pharmacodynamics, and efficacy in well-controlled infection models and human trials, as well as to clarify which resistance mechanisms and bacterial species are most susceptible to EDTA-based potentiation. In phytoremediation, priorities include defining conditions where EDTA improves net remediation outcomes without unacceptable plant growth penalties or environmental risks (e.g., metal leaching/mobilization beyond the rhizosphere), and comparing EDTA to alternative chelators or agronomic amendments across soils and crops. In dentistry, additional work is needed to connect chemical changes and protein release to long-term clinical outcomes (e.g., dentin integrity, regenerative success) and to optimize protocols that balance demineralization with preservation of the organic matrix. For cardiovascular chelation, further adequately powered confirmatory trials, mechanistic studies, and careful assessment of benefit–risk in defined patient subgroups are needed to resolve remaining uncertainty suggested by multiplicity-adjusted analyses.

1. What conditions has EDTA been studied for?

  • Antibiotic-resistant Gram-negative bacterial infections (adjuvant therapy): Studied as an antibiotic “helper” to restore activity of colistin against colistin-resistant organisms (e.g., colistin-resistant Salmonella), including strains carrying mcr-1 (mobile colistin resistance).

  • Biofilm-associated infections: Studied in a drug-delivery formulation with gentamicin (niosome-encapsulated GENT-EDTA) to reduce Klebsiella pneumoniae biofilm formation and antibiotic resistance.

  • Cardiovascular disease after myocardial infarction (MI): An EDTA-based infusion chelation regimen studied in the Trial to Assess Chelation Therapy (TACT), including a prespecified subgroup analysis in patients with diabetes.

  • Dental/endodontic applications: Used as a chelating/irrigant solution (e.g., 1–17% EDTA) to decalcify dentin and facilitate release of dentin matrix proteins and alter mineral content.

  • Heavy metal contamination and toxicity (mostly plant/soil studies): Studied for effects on uptake/toxicity of arsenic in Pisum sativum, and to enhance phytoextraction of cadmium (spider plant) and copper (sunflower; EDTA alone or with IAA).

  • Gut barrier function research marker (animal study): Chromium-EDTA (Cr-EDTA) used as a permeability marker to assess gastrointestinal barrier function in transported cattle (this is a measurement tool rather than a treatment).

2. Does it work in treating those conditions? Summarize the evidence.

  • Colistin-resistant bacterial infections (preclinical evidence): In vitro, EDTA alone enhanced colistin activity, and EDTA combined with baicalin showed stronger synergy, reversing colistin resistance across tested Salmonella strains. Mechanistic work in the study reports effects on mcr-1 expression and inhibition of MCR-1, plus broader pathway effects (e.g., LPS modification and efflux pump function). In vivo, the triple combination (colistin + baicalin + EDTA) reduced bacterial loads in liver and spleen compared with mono- or two-drug regimens. This supports “works” as an adjuvant in models, but it is not human clinical evidence.

  • Restoring colistin sensitivity (preclinical evidence): Another abstract reports that berberine + EDTA “substantially restored” colistin sensitivity against colistin-resistant Gram-negative bacteria (details truncated in the provided text). This is supportive but incomplete from the excerpt.

  • Klebsiella pneumoniae biofilm/AMR (preclinical evidence): Niosome-encapsulated gentamicin + EDTA reduced biofilm formation by multiple detection methods, lowered MIC/MBC (as described), and altered expression of biofilm-related genes (mrkA, ompA, vzm). Toxicity was assessed in HFF cells via MTT, suggesting some evaluation of cytotoxicity, but this remains laboratory/preclinical evidence.

  • Post-MI cardiovascular outcomes (human randomized trial evidence in a subgroup): In TACT, among patients aged ≥50 with diabetes and prior MI, EDTA chelation reduced the primary composite endpoint over 5 years (25% vs 38%; HR 0.59; 95% CI 0.44–0.79; P<0.001). The study notes the finding remained significant after adjustment for multiple subgroup comparisons. No benefit was seen in non-diabetes participants (interaction P=0.004). The authors explicitly state this is not sufficient to recommend routine use and that replication/mechanism work is needed.

  • Dental/endodontic uses (mechanistic/functional evidence): EDTA produced chelation-related decreases in phosphate/carbonate peaks in dentin (Raman spectroscopy) and enabled release/solubilization of proteins such as TGF-β1, VEGF, and DSP. This supports EDTA’s functional role as a chelator/conditioner in endodontic protocols, not a systemic “treatment” of disease.

  • Heavy metal uptake/toxicity (plant/soil evidence): EDTA increased bioavailable cadmium and increased Cd concentrations in shoots/roots (e.g., highest Cd in EDTA-0.2), but high-dose EDTA reduced plant biomass, raising concerns about efficiency. In copper-contaminated soil, EDTA (especially with IAA) increased Cu absorption/accumulation and mitigated some growth impairment. These findings are relevant to phytoremediation and plant physiology, not direct human therapy.

3. What health benefits does it have?

  • Potential cardiovascular benefit in a specific high-risk group (evidence-limited): In TACT’s prespecified diabetes subgroup (post-MI, age ≥50), EDTA-based chelation was associated with fewer cardiovascular events over 5 years (primary composite endpoint HR 0.59). This suggests a possible benefit in that population, but the study emphasizes the need for replication and does not support routine use.

  • Potential to enhance antibiotic effectiveness (preclinical): EDTA acted as an antibiotic adjuvant, enhancing colistin activity against colistin-resistant bacteria in vitro, and in combination regimens reduced bacterial burdens in animal infection models. It also contributed to anti-biofilm/anti-resistance effects when paired with gentamicin in a delivery system against K. pneumoniae.

  • Dental procedural benefit (local use): As a chelating agent, EDTA reduces mineral content of dentin and facilitates release of growth factors/proteins (e.g., TGF-β1, VEGF, DSP), supporting its use in regenerative endodontic conditioning protocols.

Important limitation: Several “benefits” above are either preclinical (bacteria, biofilms) or procedural (dentistry). The only clear human outcomes evidence in the studies reviewed here is the TACT subgroup analysis in post-MI patients with diabetes.

4. Does it have any downsides or side effects?

  • Uncertainty and non-generalizability in cardiovascular use: Even with positive findings in the diabetes subgroup, the TACT abstract explicitly states the evidence is insufficient to recommend routine chelation therapy for all post-MI patients with diabetes and calls for replication and mechanism clarification.

  • Potential for harm in biological systems via chelation (indirect evidence from plant studies): In cadmium phytoremediation, higher EDTA (EDTA-0.2) was associated with the lowest plant biomass, despite increasing Cd uptake—suggesting that stronger chelation can impair growth/viability in that model. While plants are not humans, it supports the general principle that EDTA can meaningfully alter metal availability and biological function.

  • Local tissue effects in dentistry are intended but represent “damage” to mineral structure: EDTA decreased phosphate/carbonate peaks in dentin (demineralization/chelation). This is beneficial for smear-layer removal and conditioning, but it also reflects alteration of tooth mineral content; concentration/exposure time matter clinically (the study compares 1%–17% EDTA and other acids).

  • Cell toxicity considerations (limited data in excerpt): The gentamicin-EDTA niosome study included an MTT assay on HFF cells to evaluate toxicity, implying cytotoxicity is a relevant concern, but the study text does not report quantitative safety outcomes.

Note: The studies reviewed here do not enumerate classic systemic EDTA adverse effects (e.g., electrolyte disturbances, kidney effects). Any safety conclusions beyond what is above would require additional sources.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

The studies reviewed here do not report pharmacogenomic analyses or genotype-stratified responses to EDTA (e.g., variants affecting chelation handling, renal transport, oxidative stress pathways, or cardiovascular outcomes). The closest “stratification” is clinical (diabetes vs non-diabetes) in TACT, where benefit was observed in diabetes but not in non-diabetes; this is not a genetic variation and does not establish pharmacogenomic guidance.

References

  1. Synergistic antibacterial activity of baicalin and EDTA in combination with colistin against colistin-resistant Salmonella.
    Xiao-Die Cui, Jun-Kai Zhang, Ya-Wei Sun, Feng-Bin Yan, Jin-Feng Zhao, Dan-Dan He, Yu-Shan Pan, Li Yuan, Ya-Jun Zhai, Gong-Zheng Hu (2023) - Poultry science
  2. EDTA-Modified Carbapenem Inactivation Method: a Phenotypic Method for Detecting Metallo-β-Lactamase-Producing
    M M Sfeir, J A Hayden, K A Fauntleroy, C Mazur, J K Johnson, P J Simner, S Das, M J Satlin, S G Jenkins, L F Westblade (2019) - Journal of clinical microbiology
  3. Comparative effect of calcium and EDTA on arsenic uptake and physiological attributes of Pisum sativum.
    Marina Rafiq, Muhammad Shahid, Ghulam Abbas, Saliha Shamshad, Sana Khalid, Nabeel Khan Niazi, Camille Dumat (2017) - International journal of phytoremediation
  4. Demineralization, Collagen Modification and Remineralization Degree of Human Dentin after EDTA and Citric Acid Treatments.
    Maria Giovanna Gandolfi, Paola Taddei, Anna Pondrelli, Fausto Zamparini, Carlo Prati, Gianrico Spagnuolo (2018) - Materials (Basel, Switzerland)
  5. Effect of farmyard manure, elemental sulphur and EDTA on growth and phytoextraction of cadmium by spider plants (Chlorophytum comosum L.) under Cd stress.
    Muhammad Zia-Ur-Rehman, Arisha Mubsher, Muhammad Rizwan, Muhammad Usman, Muhammad Jafir, Muhammad Umair, Hesham F Alharby, Atif A Bamagoos, Rahma Alshamrani, Shafaqat Ali (2023) - Chemosphere
  6. Effect of chitosan irrigant solutions on the release of bioactive proteins from root dentin.
    Sara Quijano-Guauque, Lilia J Bernal-Cepeda, Félix G Delgado, Jaime E Castellanos, Claudia García-Guerrero (2023) - Clinical oral investigations
  7. EDTA and IAA Ameliorates Phytoextraction Potential and Growth of Sunflower by Mitigating Cu-Induced Morphological and Biochemical Injuries.
    Naila Shah, Muhammad Irshad, Anwar Hussain, Muhammad Qadir, Waheed Murad, Asif Khan, Muhammad Awais, Abdulwahed Fahad Alrefaei, Sajid Ali (2023) - Life (Basel, Switzerland)
  8. The effect of an EDTA-based chelation regimen on patients with diabetes mellitus and prior myocardial infarction in the Trial to Assess Chelation Therapy (TACT).
    Esteban Escolar, Gervasio A Lamas, Daniel B Mark, Robin Boineau, Christine Goertz, Yves Rosenberg, Richard L Nahin, Pamela Ouyang, Theodore Rozema, Allan Magaziner, Richard Nahas, Eldrin F Lewis, Lauren Lindblad, Kerry L Lee (2014) - Circulation. Cardiovascular quality and outcomes
  9. Antibacterial and antibiofilm effects of essential oil components, EDTA and HLE disinfectant solution on
    Natacha Caballero Gómez, Julia Manetsberger, Nabil Benomar, Sonia Castillo Gutiérrez, Hikmate Abriouel (2022) - Frontiers in microbiology
  10. In silico and in vitro studies of GENT-EDTA encapsulated niosomes: A novel approach to enhance the antibacterial activity and biofilm inhibition in drug-resistant Klebsiella pneumoniae.
    Iman Akbarzadeh, Niloufar Rezaei, Saina Bazzazan, Maryam Naderi Mezajin, Afsoun Mansouri, Hamideh Karbalaeiheidar, Shamim Ashkezari, Zahra Salehi Moghaddam, Zahra Asghari Lalami, Ebrahim Mostafavi (2023) - Biomaterials advances
  11. Effect of a molasses-based liquid supplement on gastrointestinal tract barrier function, inflammation, and performance of newly received feedlot cattle before and after a transport stress.
    Breno C Silva, Leticia A Godoi, Chanadol Supapong, Bryce Bitsie, Sebastian C Valadares Filho, Jon P Schoonmaker (2023) - Journal of animal science
  12. Chelation Therapy in Patients With Cardiovascular Disease: A Systematic Review.
    Filippo Ravalli, Xavier Vela Parada, Francisco Ujueta, Rachel Pinotti, Kevin J Anstrom, Gervasio A Lamas, Ana Navas-Acien (2022) - Journal of the American Heart Association
  13. The Effect of Heating to Intracanal Temperature on the Stability of Sodium Hypochlorite Admixed with Etidronate or EDTA for Continuous Chelation.
    Patricia P Wright, Bill Kahler, Laurence J Walsh (2019) - Journal of endodontics
  14. EDTA Chelation Therapy for the Treatment of Neurotoxicity.
    Alessandro Fulgenzi, Maria Elena Ferrero (2019) - International journal of molecular sciences
  15. Effect of EDTA and citric acid on absorption of heavy metals and growth of Moso bamboo.
    Xiaowei Zhang, Bin Zhong, Mohammad Shafi, Jia Guo, Chen Liu, Hua Guo, Danli Peng, Ying Wang, Dan Liu (2018) - Environmental science and pollution research international
  16. UV-shielding alginate films crosslinked with Fe
    Yu Bai, Yun Zhao, Yang Li, Jiachao Xu, Xiaoting Fu, Xin Gao, Xiangzhao Mao, Zhaoyong Li (2020) - Carbohydrate polymers
  17. Effect of sodium hypochlorite and EDTA irrigation, individually and in alternation, on dentin microhardness at the furcation area of mandibular molars.
    Danilo Zaparolli, Paulo César Saquy, Antonio Miranda Cruz-Filho (2012) - Brazilian dental journal
  18. Comparative study of debris and smear layer removal with EDTA and Er,Cr:YSGG laser.
    Paloma Montero-Miralles, Daniel Torres-Lagares, Juan-Jose Segura-Egea, Maria-Ángeles Serrera-Figallo, Jose-Luis Gutierrez-Perez, Gabriel Castillo-Dali (2018) - Journal of clinical and experimental dentistry


Related

This article summarizes published research for educational purposes. It is not medical advice. Talk to your doctor before starting, stopping, or changing any supplement or medication.

Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!